202 related articles for article (PubMed ID: 1330489)
21. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
Kanatani A; Ishihara A; Asahi S; Tanaka T; Ozaki S; Ihara M
Endocrinology; 1996 Aug; 137(8):3177-82. PubMed ID: 8754736
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
23. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Holliday ND; Cox HM
Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
[TBL] [Abstract][Full Text] [Related]
24. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas.
Sheikh SP; Roach E; Fuhlendorff J; Williams JA
Am J Physiol; 1991 Feb; 260(2 Pt 1):G250-7. PubMed ID: 1847590
[TBL] [Abstract][Full Text] [Related]
25. Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines.
van Valen F; Winkelmann W; Jürgens H
J Cancer Res Clin Oncol; 1992; 118(7):529-36. PubMed ID: 1320624
[TBL] [Abstract][Full Text] [Related]
26. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain.
Dumont Y; Fournier A; St-Pierre S; Quirion R
J Neurosci; 1993 Jan; 13(1):73-86. PubMed ID: 8423484
[TBL] [Abstract][Full Text] [Related]
27. Solubilization and affinity purification of the Y2 receptor for neuropeptide Y and peptide YY from rabbit kidney.
Sheikh SP; Hansen AP; Williams JA
J Biol Chem; 1991 Dec; 266(35):23959-66. PubMed ID: 1660889
[TBL] [Abstract][Full Text] [Related]
28. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines.
Sheikh SP; O'Hare MM; Tortora O; Schwartz TW
J Biol Chem; 1989 Apr; 264(12):6648-54. PubMed ID: 2708330
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y receptor binding sites in rat brain: differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity.
Lynch DR; Walker MW; Miller RJ; Snyder SH
J Neurosci; 1989 Aug; 9(8):2607-19. PubMed ID: 2549216
[TBL] [Abstract][Full Text] [Related]
30. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia.
Holliday ND; Pollock EL; Tough IR; Cox HM
Can J Physiol Pharmacol; 2000 Feb; 78(2):126-33. PubMed ID: 10737675
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.
Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Inoue T; Oya M; Baba S
Endocrinology; 1990 Aug; 127(2):934-41. PubMed ID: 2164925
[TBL] [Abstract][Full Text] [Related]
32. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
Singh G; Singh L; Raufman JP
Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
[TBL] [Abstract][Full Text] [Related]
33. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
Dautzenberg FM; Neysari S
Pharmacology; 2005 Dec; 75(1):21-9. PubMed ID: 15908753
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical distribution of neuropeptide Y, peptide YY, pancreatic polypeptide-like immunoreactivity and their receptors in the epidermal skin of healthy women.
Dumont Y; Bastianetto S; Duranton A; Breton L; Quirion R
Peptides; 2015 Aug; 70():7-16. PubMed ID: 26002416
[TBL] [Abstract][Full Text] [Related]
35. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.
Dumont Y; Fournier A; St-Pierre S; Quirion R
J Pharmacol Exp Ther; 1995 Feb; 272(2):673-80. PubMed ID: 7853181
[TBL] [Abstract][Full Text] [Related]
36. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
[TBL] [Abstract][Full Text] [Related]
37. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
Chen CH; Stephens RL; Rogers RC
Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
[TBL] [Abstract][Full Text] [Related]
38. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
Hegde SS; Bonhaus DW; Stanley W; Eglen RM; Moy TM; Loeb M; Shetty SG; DeSouza A; Krstenansky J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1261-6. PubMed ID: 8531090
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
